International Therapeutics, Inc. (ITI) was a privately held Seattle biotechnology company focused on the discovery and development of novel anti-viral therapies. The Company was dedicated to finding new, safe and effective ways to combat HIV, a virus infecting over 42 million people worldwide.
ITI's novel technologies include nuclear entry inhibition and RNA intervention. For more information about the approaches that ITI used to develop new drugs against HIV, go to ITI’s Science page.
International Therapeutics, Inc.
600 Broadway Medical Center, Suite 510
Seattle, WA 98122